Difference between revisions of "Team:Waterloo"

m
Line 6: Line 6:
 
             <div class="col-sm-5">
 
             <div class="col-sm-5">
 
                 <img src="/wiki/images/5/5e/Waterloo_crispier_logo_transparent.png" alt="Waterloo iGEM CRISPieR Logo" class="img-responsive"/>
 
                 <img src="/wiki/images/5/5e/Waterloo_crispier_logo_transparent.png" alt="Waterloo iGEM CRISPieR Logo" class="img-responsive"/>
            </div>
 
            <div class="col-sm-3 text-center">
 
                <h2 class="orangetext no-border">Cas9 PAM Flexibility</h2>
 
 
             </div>
 
             </div>
 
             <div class="col-sm-2 text-center">
 
             <div class="col-sm-2 text-center">
 
                 <h2 class="bluetext no-border">Simple sgRNA Exchange</h2>
 
                 <h2 class="bluetext no-border">Simple sgRNA Exchange</h2>
 +
            </div>
 +
            <div class="col-sm-3 text-center">
 +
                <h2 class="orangetext no-border">Cas9 PAM Flexibility</h2>
 
             </div>
 
             </div>
 
             <div class="col-sm-2 text-center">
 
             <div class="col-sm-2 text-center">
Line 25: Line 25:
 
     </p>
 
     </p>
 
     <p>
 
     <p>
         We’re making it easy to test different sgRNA designs: restriction sites added to the sgRNA backbone allow 20 nucleotide target sequences to be swapped without excessive cloning.
+
         <strong>Simple sgRNA Exchange</strong>: We’re making it easy to test different sgRNA designs: restriction sites added to the sgRNA backbone allow 20 nucleotide target sequences to be swapped without excessive cloning.
 
     </p>
 
     </p>
 
     <p>
 
     <p>
         Additionally, we’re applying recent research on viable mutations within Cas9’s PAM-interacting domain to design (d)Cas9 variants that bind to novel PAM sites, moving towards the goal of a suite of variants that can bind any desired sequence. We believe our re-engineered CRISPR-Cas9 will give biologists increased ability to optimize targeting in many applications.
+
         <strong>Cas9 PAM Flexibility</strong>: We’re applying recent research on viable mutations within Cas9’s PAM-interacting domain to design (d)Cas9 variants that bind to novel PAM sites, moving towards the goal of a suite of variants that can bind any desired sequence. We believe our re-engineered CRISPR-Cas9 will give biologists increased ability to optimize targeting in many applications.
 
     </p>
 
     </p>
 
     <p>
 
     <p>
         The application we chose to explore is a proof-of-concept antiviral system defending the model plant <i>Arabidopsis thaliana</i> against Cauliflower Mosaic Virus, which would benefit from testing a large number of possible sgRNAs in the viral genome.
+
         <strong>CRISPR Plant Defense</strong>: The application we chose to explore is a proof-of-concept antiviral system defending the model plant <i>Arabidopsis thaliana</i> against Cauliflower Mosaic Virus, which would benefit from testing a large number of possible sgRNAs in the viral genome.
 
     </p>
 
     </p>
  

Revision as of 19:39, 16 September 2015

Waterloo iGEM CRISPieR Logo

Simple sgRNA Exchange

Cas9 PAM Flexibility

CRISPR Plant Defense

Re-engineering CRISPR-Cas9 with functional applications in eukaryotic systems

CRISPR-Cas9 is an exciting tool for synthetic biologists because it can target and edit genomes with unprecedented specificity. Our team is attempting to re-engineer CRISPR to make it more flexible and easier to use.

Simple sgRNA Exchange: We’re making it easy to test different sgRNA designs: restriction sites added to the sgRNA backbone allow 20 nucleotide target sequences to be swapped without excessive cloning.

Cas9 PAM Flexibility: We’re applying recent research on viable mutations within Cas9’s PAM-interacting domain to design (d)Cas9 variants that bind to novel PAM sites, moving towards the goal of a suite of variants that can bind any desired sequence. We believe our re-engineered CRISPR-Cas9 will give biologists increased ability to optimize targeting in many applications.

CRISPR Plant Defense: The application we chose to explore is a proof-of-concept antiviral system defending the model plant Arabidopsis thaliana against Cauliflower Mosaic Virus, which would benefit from testing a large number of possible sgRNAs in the viral genome.

Top